119-HR-4348 Journalist Public Summary
119 · HR 4348 To reauthorize the Kay Hagan Tick Act, and for other purposes.
Reauthorizes federal tick-borne disease programs through 2030 and fine‑tunes them to help CDC, research centers, and state health departments better find, report, prevent, and respond to Lyme and other vector‑borne illnesses. [1]Congress.gov — Text - H.R. 4348 (Introduced in House)
Headline Summary
Reups national tick‑borne disease programs through 2030 and strengthens coordination among CDC, regional research centers, and state health departments. [1]Congress.gov — Text - H.R. 4348 (Introduced in House)
What It Does
H.R. 4348 extends existing authorities created by the Kay Hagan Tick Act. It continues the national strategy and Regional Centers of Excellence in Vector‑Borne Disease and keeps extra support flowing to health departments from fiscal years 2026–2030. The bill also updates consultation language (removing a reference to the now‑expired Tick‑Borne Disease Working Group) and explicitly emphasizes building capacity to identify, report, prevent, and respond to these diseases. [1]Congress.gov — Text - H.R. 4348 (Introduced in House)
Why it matters: Lyme disease is the most commonly reported vector‑borne illness in the U.S.; states reported over 89,000 Lyme cases in 2023, and CDC estimates roughly 476,000 people are diagnosed and treated for Lyme each year—illustrating the scale of the problem these programs target. [2]CDC — Lyme Disease Surveillance and Data | Lyme Disease | CDC
Who’s For It
- Bipartisan House backers: Sponsored by Rep. Chris Smith (R‑NJ) with support from members of both parties. [1]Congress.gov — Text - H.R. 4348 (Introduced in House)
- House Energy & Commerce Committee: Advanced the bill to the full House by a 48–0 vote on May 21, 2026. [3]House Energy & Commerce Committee (majority) — E&C Advances 16 Bills to Full Ho…
- Patient and advocacy groups: Lyme advocates have publicly urged reauthorization; a Senate sponsor’s release features support from Center for Lyme Action. [4]U.S. Senate (Sen. Angus King) — Senators King, Collins, Smith Introduce Bill to…
- Senate activity: A related Senate reauthorization advanced unanimously in the HELP Committee, signaling broad bipartisan interest. [5]U.S. Senate (Sen. Susan Collins) — Senator Collins Advocates for Kay Hagan Tick…
Who’s Against It
No organized opposition surfaced during House committee consideration; the full committee’s 48–0 vote suggests broad bipartisan support at this stage. [3]House Energy & Commerce Committee (majority) — E&C Advances 16 Bills to Full Ho…
What’s Next
After clearing the House Energy & Commerce Committee, the bill awaits a vote by the full House. If it passes, the Senate would take it up; senators have already moved a companion reauthorization through committee. [3]House Energy & Commerce Committee (majority) — E&C Advances 16 Bills to Full Ho…
- [1] Text - H.R. 4348 (Introduced in House) Congress.gov
- [2] Lyme Disease Surveillance and Data | Lyme Disease | CDC CDC
- [3] E&C Advances 16 Bills to Full House House Energy & Commerce Committee (majority)
- [4] Senators King, Collins, Smith Introduce Bill to Combat Lyme and Other Tick-Borne Diseases U.S. Senate (Sen. Angus King)
- [5] Senator Collins Advocates for Kay Hagan Tick Act as Bill Unanimously Advances out of Committee U.S. Senate (Sen. Susan Collins)
Discussion